Literature DB >> 23504329

Dyslipidemia and inflammation in patients with inflammatory bowel disease.

Fatih Karaahmet, Omer Basar, Sahin Coban, Ilhami Yuksel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23504329     DOI： 10.1007/s10620-013-2614-0

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  7 in total

1.  Statins and cancer risk: a meta-analysis.

Authors:  Krista M Dale; Craig I Coleman; Nickole N Henyan; Jeffrey Kluger; C Michael White
Journal:  JAMA       Date:  2006-01-04       Impact factor: 56.272

2.  Post-diagnosis statin use and breast recurrence sites in early stage breast cancer survivors.

Authors:  Hakan Harputluoglu; Omer Dizdar; Fatih Karaahmet; Kadri Altundag
Journal:  Breast Cancer Res Treat       Date:  2007-09-13       Impact factor: 4.872

3.  Dyslipidemia and lipoprotein profiles in patients with inflammatory bowel disease.

Authors:  Raja Shekhar R Sappati Biyyani; Brian S Putka; Kevin D Mullen
Journal:  J Clin Lipidol       Date:  2010-10-28       Impact factor: 4.766

4.  Impact of Clostridium difficile colitis on 5-year health outcomes in patients with ulcerative colitis.

Authors:  S K Murthy; A H Steinhart; J Tinmouth; P C Austin; N Daneman; G C Nguyen
Journal:  Aliment Pharmacol Ther       Date:  2012-10-14       Impact factor: 8.171

5.  Clinically important interaction between statin drugs and Clostridium difficile toxin?

Authors:  Timothy McGuire; Paul Dobesh; Don Klepser; Mark Rupp; Keith Olsen
Journal:  Med Hypotheses       Date:  2009-08-04       Impact factor: 1.538

6.  The fatty acid profile of the erythrocyte membrane in initial-onset inflammatory bowel disease patients.

Authors:  Kan Uchiyama; Shunichi Odahara; Makoto Nakamura; Shigeo Koido; Kiyohiko Katahira; Hiromi Shiraishi; Toshifumi Ohkusa; Kiyotaka Fujise; Hisao Tajiri
Journal:  Dig Dis Sci       Date:  2013-01-11       Impact factor: 3.199

Review 7.  Statins for infection and sepsis: a systematic review of the clinical evidence.

Authors:  Matthew E Falagas; Gregory C Makris; Dimitrios K Matthaiou; Petros I Rafailidis
Journal:  J Antimicrob Chemother       Date:  2008-02-07       Impact factor: 5.790
  7 in total
  2 in total

Review 1.  Cardiovascular complications in inflammatory bowel disease.

Authors:  Rudolf Schicho; Gunther Marsche; Martin Storr
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

Review 2.  Care of inflammatory bowel disease patients in remission.

Authors:  Charumathi Raghu Subramanian; George Triadafilopoulos
Journal:  Gastroenterol Rep (Oxf)       Date:  2016-10-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.